For: | Spera AM. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment. World J Virol 2022; 11(5): 275-282 [PMID: 36188738 DOI: 10.5501/wjv.v11.i5.275] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/275.htm |
Number | Citing Articles |
1 |
Emilia Lazarou, Christos Koutsianas, Panayotis K. Vlachakis, Panagiotis Theofilis, Dimitrios Vassilopoulos, Costas Tsioufis, George Lazaros, Dimitris Tousoulis. Novel Treatments in Refractory Recurrent Pericarditis. Pharmaceuticals 2024; 17(8): 1069 doi: 10.3390/ph17081069
|
2 |
Emilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, George Lazaros, Dimitrios Vassilopoulos, Charalambos Vlachopoulos, Costas Tsioufis, Massimo Imazio, Antonio Brucato, Dimitris Tousoulis. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis. Life 2024; 14(3): 305 doi: 10.3390/life14030305
|
3 |
Ioannis Braimakis, Sofia Vasileiadi, Eleni-Myrto Trifylli, Nikolaos Papadopoulos, Melanie Deutsch. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?. Livers 2023; 3(3): 347 doi: 10.3390/livers3030026
|
4 |
Na Wei, Bin Zheng, Hongfu Cai, Na Li, Jing Yang, Maobai Liu. Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1403805
|
5 |
Galina I. Gridneva, Boris S. Belov, Evgeniia S. Aronova. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review. Terapevticheskii arkhiv 2024; 96(5): 523 doi: 10.26442/00403660.2024.05.202707
|